No connection

Search Results

Corporate Score 32 Bearish

NuScale Power Faces Commercialization Hurdle Despite SMR Potential

Apr 27, 2026 12:35 UTC
SMR
Long term

NuScale Power's stock has plummeted 75% from its peak as the company struggles to secure its first commercial reactor sale. While the technology is regulatory-approved, the lack of a paying customer leaves the firm in a high-risk position.

  • Shares have declined 75% from 52-week highs
  • SMR design is regulatory-approved and factory-buildable
  • Critical lack of a first confirmed commercial customer
  • Strategic orders placed for long-lead-time parts for 12 reactors
  • Potential growth linked to AI and EV power demands
  • Ongoing support and funding from the U.S. government

NuScale Power (NYSE: SMR) is attempting to pioneer the commercialization of small modular reactors (SMRs), but the company currently finds itself in a precarious financial position. Despite an initial rally driven by broader nuclear energy enthusiasm, the stock has retreated significantly, falling 75% from its 52-week high. The company's value proposition rests on its ability to manufacture nuclear reactors in a factory setting, allowing for easier transport and scalable deployment. While the design has received regulatory approval, the transition from theoretical success to commercial viability remains the primary obstacle for the start-up. Currently, NuScale lacks a signed contract for its first reactor sale. Although the company has engaged in discussions with foreign power entities and U.S. firms, no concrete orders have materialized. To mitigate future lead times, the company has proactively ordered parts for up to 12 reactors to ensure rapid deployment once a contract is signed. The long-term outlook is supported by the surging electricity demands of artificial intelligence and electric vehicle infrastructure. Furthermore, the U.S. government has provided funding and support for SMR technology, and NuScale is collaborating with utilities slated for government assistance. Despite these tailwinds, the stock remains a speculative play. Until a first sale is finalized and the technology is proven in a commercial environment, the company remains a high-risk asset, suggesting that cautious investors may prefer to remain on the sidelines.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI Chat
Markets
Profile